NXP Semiconductors N.V. vs Takeda Pharmaceutical Company Limited
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
NXP Semiconductors N.V.
$58.7B
์์ #247
Takeda Pharmaceutical Company Limited
$59.0B
์์ #245
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- NXP Semiconductors N.V.์ด(๊ฐ) 2020๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Takeda Pharmaceutical Company Limited์ด(๊ฐ) 2022๋ ๊น์ง NXP Semiconductors N.V.์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- NXP Semiconductors N.V.์ด(๊ฐ) 2023๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Takeda Pharmaceutical Company Limited์ด(๊ฐ) 2026๋ ๊น์ง NXP Semiconductors N.V.์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | NXP Semiconductors N.V. | Takeda Pharmaceutical Company Limited | ์ ๋ |
|---|---|---|---|
| 2026 | $58.7B | $59.0B | Takeda Pharmaceutical Company Limited |
| 2025 | $54.3B | $50.3B | NXP Semiconductors N.V. |
| 2024 | $51.0B | $41.6B | NXP Semiconductors N.V. |
| 2023 | $55.4B | $38.6B | NXP Semiconductors N.V. |
| 2022 | $37.3B | $37.6B | Takeda Pharmaceutical Company Limited |
| 2021 | $52.9B | $27.3B | NXP Semiconductors N.V. |
| 2020 | $36.5B | $31.2B | NXP Semiconductors N.V. |
| 2019 | $28.8B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2018 | $16.4B | $28.0B | Takeda Pharmaceutical Company Limited |
| 2017 | $26.1B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $21.9B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $18.8B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $17.1B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $10.3B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $5.9B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $3.4B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $4.7B | $22.3B | Takeda Pharmaceutical Company Limited |